128 related articles for article (PubMed ID: 11965574)
1. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma.
Cheng SJ; Freeman RB; Wong JB
Liver Transpl; 2002 Apr; 8(4):323-8. PubMed ID: 11965574
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
Ioannou GN; Perkins JD; Carithers RL
Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
[TBL] [Abstract][Full Text] [Related]
3. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
5. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
Moonka D; Castillo E; Kumer S; Abouljoud M; Divine G; Pelletier S
Transplant Proc; 2009; 41(1):216-8. PubMed ID: 19249517
[TBL] [Abstract][Full Text] [Related]
6. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
8. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
9. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
10. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
Yao FY; Bass NM; Ascher NL; Roberts JP
Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors influencing postoperative survival in patients with Wu FS; Zhao WH; Liang TB; Ren GP; Ma ZM; Teng LS
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):579-83. PubMed ID: 15938929
[TBL] [Abstract][Full Text] [Related]
13. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Huang YH; Su CW; Lin HC; Chiang JH; Chiou YY; Huo SC; Lee PC; Lee SD
Clin Transplant; 2008; 22(4):469-75. PubMed ID: 18318736
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
15. Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target.
Washburn K
Transplant Rev (Orlando); 2010 Jan; 24(1):11-7. PubMed ID: 19942101
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
17. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
[TBL] [Abstract][Full Text] [Related]
18. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
[TBL] [Abstract][Full Text] [Related]
19. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
De Giorgio M; Vezzoli S; Cohen E; Armellini E; Lucà MG; Verga G; Pinelli D; Nani R; Valsecchi MG; Antolini L; Colledan M; Fagiuoli S; Strazzabosco M
Liver Transpl; 2010 Apr; 16(4):503-12. PubMed ID: 20373461
[TBL] [Abstract][Full Text] [Related]
20. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
